Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy

The Lancet

Volumn 339, Issue 8794, 1992, Pages 640-644

  Sheridan, W P ^a   Fox, R M ^a   Begley, C G ^a,b   Maher, D ^a   McGrath, K M ^a   Juttner, C A ^c   To, L Bik ^c   Szer, J ^d   Mostyn, G ^e  

^a Royal Melbourne Hospital ^*  (Romania)

^b WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c ROYAL ADELAIDE HOSPITAL   (Australia)

^d Clinical Haematology and Bone Marrow Transplantation Unit Alfred Hospital Prahran Victoria Romania ^*  (Romania)

^e LUDWIG INSTITUTE FOR CANCER RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CONTROLLED STUDY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; STEM CELL; SUBCUTANEOUS DRUG ADMINISTRATION;

ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS; BLOOD PLATELETS; BONE MARROW TRANSPLANTATION; ERYTHROID PROGENITOR CELLS; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMAN; LEUKOCYTE COUNT; MALE; MIDDLE AGE; RECOMBINANT PROTEINS; SUPPORT, NON-U.S. GOV'T; TIME FACTORS;

EID: 0026504705     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/0140-6736(92)90795-5     Document Type: Article

References (27)

1. The molecular biology and cloning of the granulocyte-macrophage colony-stimulating factors
2. The role of colony stimulating factors in cancer therapy
3. Granulocyte colony-stimulating factor (G-CSF) and neutrophil recovery after high-dose chemotherapy and autologous bone-marrow transplantation
4. Recombinant human granulocyte colony-stimulating factor hastens granulocyte recovery after high-dose chemotherapy and autologous bone marrow transplanttion in Hodgkin's disease
5. Use of recombinant human granulocyte-macrophage colony-stimulating factor in autologous marrow transplantation for lymphoid malignancies
6. GM-CSF accelerates neutrophil recovery after autologous bone marrow transplantation for Hodgkin's disease
7. In vivo administration of recombinant human granulocyte/macrophage colony-stimulating factor in acute lymphoblastic leukemia patients receiving purged autografts
8. Effects of recombinant granulocyte colony-stimulating factor on hematopoeitic progenitor cells in cancer patients
9. Granulocyte-macrophage colony-stimulating factor expands the circulating haemopoietic progenitor cell compartment in man
10. Collection, manipulation and freezing of haemopoietic stem cells
11. High dose chemotherapy with busulphan and cyclophosphamide and bone marrow transplantation for drug-sensitive malignancies in adults: a preliminary report
12. High levels of circulating haemopoietic stem cells in very early remission from acute non-lymphoblastic leukaemia and their collection and cryopreservation
13. Phase I study of granulocyte colony-stimulating factor in patients with transitional cell carcinoma of the urothelium
14. Transplantation potential of peripheral blood stem cells induced by granulocyte colony-stimulating factor
15. Peripheral blood stem cells collected in very early remission produce rapid and sustained autologous hematopoietic reconstitution in acute non-lymphoblastic leukaemia
16. An unusual pattern of haemopoietic reconstitution in patients with acute myeloid leukaemia transplanted with autologous recovery phase peripheral blood
17. Granulocyte-macrophage colony-stimulating factor to harvest circulating haemopoietic stem cells for autotransplantation
18. Successful autologous transplantation of blood stem cells mobilized with recombinant human granulocyte-macrophage colony-stimulating factor
19. High dose combination alkylating agents with autologous bone marrow transplantation for primary and metastatic breast cancer.
20. Durable and complete hematopoeitic reconstitution after autografting of rhGM-CSF exposed peripheral blood progenitor cells
21. Dose intensive regimens in breast cancer: the Dana Farber Cancer Institute and Beth Israel experience
22. Granulocyte-macrophage colony-stimulating factor requires interaction with accessory cells or granulocyte-colony stimulating factor for full stimulation of human myeloid progenitors
23. Action of interleukin-3, G-CSF, and GM-CSF on highly enriched human hematopoietic progenitor cells: synergistic interaction of GM-CSF plus G-CSF
24. Mechanism of synergy between granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in colony formation from human marrow cells in vitro
25. Recombinant human stem cell factor synergizes with GM-CSF, G-CSF, IL-3 and EPO to stimulate human progenitor cells of the myeloid and erythroid lineages
26. Mixed hemopoietic chimerism following bone marrow transplantation for hematologic malignancies
27. Cytogenetic analysis of chimerism and leukemia relapse in chronic myelogenous leukemia patients after T cell-depleted bone marrow transplantation